Gliasite brachytherapy – a balloon catheter device for delivering radiation within the brain tumor cavity.
Convection-enhanced delivery (CED) – a neurosurgical technique that delivers a high concentration of drug therapy to the brain tumor site. HCC was one of 10 U.S. institutions involved in a clinical trial for this technique and we have the most experience with it in this country.
Skull Base Surgery Program – complex lesions of the skull base are addressed by surgical teams from Neurological Surgery, Head and Neck Surgery, Orbital surgery and Plastic Surgery employing the latest microsurgical techniques.
Pituitary Tumor Program –Subspecialty physicians from Neurological Surgery, Neuro-ophthalmology, Otolaryngology and Endocrinology unite to plan treatment, which is usually minimally invasive endoscopic surgery.
Stereotactic radiosurgery (SRS) – focused tumor radiation.
Image guided systems – minimally invasive procedures to locate and remove tumors.
Advanced imaging technology – from PET scans that analyze metabolic activity in tumors to the latest MRI machines, we have the latest imaging capabilities. MUSC’s Center for Advanced Imaging Research is also continually working on imaging innovations. Spectroscopy – chemical analysis of brain tissue to determine tumor type.
Portable CT scanner – enables bedside scans and gives physicians immediate results.
Dedicated neuroscience intensive care unit (ICU) – seven dedicated beds
Electronic medical records – enables any of the multidisciplinary team members to access a patient’s information for 24/7 involvement in the care
Video monitoring – monitors a patient’s seizure activities
